Publication | Closed Access

Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma

UrologyGenitourinary CancerMedicinePrognostic ValueAdvanced Urothelial CarcinomaImmune Checkpoint InhibitorPre-treatment Risk StratificationCancer TreatmentOncologyRadiation Oncology